Innate Pharma S.A. (EPA: IPH)
France flag France · Delayed Price · Currency is EUR
2.090
-0.020 (-0.95%)
Aug 30, 2024, 5:35 PM CET

Innate Pharma Market Cap

Innate Pharma has a market cap or net worth of €169.19 million as of August 30, 2024. Its market cap has decreased by -20.69% in one year.

Market Cap
169.19M
Enterprise Value
116.62M
Revenue
61.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.09

Market Cap Chart

Since November 1, 2006, Innate Pharma's market cap has increased from 792.12K to 169.19M, an increase of 21,258.78%. That is a compound annual growth rate of 35.07%.

History

DateMarket Cap% Change
Aug 30, 2024169.19M-19.91%
Dec 29, 2023211.24M-19.93%
Dec 30, 2022263.84M-24.98%
Dec 31, 2021351.67M28.64%
Dec 31, 2020273.37M-41.60%
Dec 31, 2019468.11M-1.49%
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro
Dec 31, 2014 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition